Case Studies

Password required

Incorrect password. Try again.

The Problem The Solution The Impact
All Case Studies
UX Leadership Stakeholder Interviews Research Synthesis Strategic Planning UX Roadmapping

Setting the UX direction for Roche's flagship digital pathology platform.

As UX lead for navify Digital Pathology, I conducted a structured stakeholder interview program across 19 project team members, organizational leaders, and company stakeholders — synthesizing findings into a prioritized UX roadmap that secured budget and executive buy-in for the year ahead.

Role UX Lead
Timeline 2026
Platform navify Digital Pathology
Deliverables 2026 UX Roadmap
nDP UX Leadership

Overview

Getting design a seat at the table.

navify Digital Pathology is Roche's flagship image viewer software — the digitization of the microscope, enabling pathologists to view, analyze, and score whole slide images remotely. Following a major point-zero release, the team faced a pivotal question: where do we go next?

Without a clear UX direction, design risked being reactive — pulled into tactical requests rather than shaping the product's future. To change that, I initiated a structured stakeholder interview program to surface the short and long-term vision for nDP from the people closest to it, and use that to define exactly how UX could best help achieve company goals.

The problem After a major point-zero release, UX had no defined direction and no seat at the table for strategic planning.
The solution Conducted 19 stakeholder interviews across 6 project functions, synthesized findings via affinity mapping, and developed a prioritized 2026 UX roadmap.
The impact Roadmap approved by project leadership with budget secured for lab visits, formative studies, expert reviews, competitive analyses, and ambitious UI improvements.
2025 roadmap with defined work versus 2026 roadmap with question marks

The Problem

No UX direction, no seat at the table.

After completing a major release, there was no defined UX strategy for what came next. Without a structured understanding of where the business, product, and engineering teams were headed, design couldn't contribute meaningfully to strategic planning — let alone lead it.

The risk was real: UX would become a feature factory, responding to requests without shaping the roadmap. Getting a seat at the table meant doing the research to earn it.

No defined UX direction post-release
Design excluded from strategic planning
Unclear business goals and success metrics
Misalignment between teams on nDP's future

The solution

19 interviews. 6 functions. One unified direction.

After a major release, UX needed to earn its place at the strategic table — not wait to be invited. I designed and ran a structured interview program across 19 stakeholders spanning 6 project functions: Business, Leadership, Product, Development, Medical Affairs, and Algorithms.

The goal was to gather ground truth on product direction directly from the people driving decisions — surfacing gaps and misalignment between teams that wouldn't appear in any meeting notes, and using the output to plan UX deliverables that demonstrably helped the team achieve their goals.

Each interview followed a consistent framework:

01 Background

Team role, mandate, and relationship to nDP — establishing context before asking about direction.

02 Critical Questions

The key questions each team needed to answer for nDP — surfacing what was unresolved or contested.

03 Vision & Plans

Short and long-term direction for their team and the platform — where they wanted nDP to go.

04 Challenges & Opportunities

The biggest obstacles nDP faced and the most significant opportunities — including potential third-party partnerships and competitive data.

05 Business Goals

Success metrics and business goals for nDP — what a good outcome actually looked like to each stakeholder.

06 UX's Role

What UX could specifically do for them — asked last, after trust was established, to get honest and actionable answers.

Responses were plotted in Lucidchart as sticky notes, mapped to themes via affinity mapping, then cross-referenced against project priorities using a three-way Venn diagram — the more priorities a theme touched, the higher it ranked for UX to act on. The output was a concrete set of objectives translated into a proposed 2026 UX roadmap, presented to project leadership for approval.

Structured interview framework across 19 stakeholders
6 project functions represented: Business, Leadership, Product, Dev, Medical Affairs, Algorithms
Affinity mapping and theme synthesis in Lucidchart
Tangible UX objectives derived from business goals
Stakeholder interview synthesis
Affinity map showing synthesized themes across all 19 stakeholder interviews, grouped by pattern and frequency.
Affinity mapping in Lucidchart
Three-way Venn diagram mapping interview themes to the project's core priorities — themes with the most overlap across priorities ranked highest for UX to address.

The impact

Budget approved. Direction set.

The roadmap was presented to project leadership and approved with full budget — giving UX the resources and mandate to execute an ambitious program of work for 2026. The interview program itself took approximately one to one-and-a-half months, including outreach to senior leaders overseeing Roche's pathology lab group, who I contacted directly to secure their participation.

Since approval, three workstreams are already underway:

  • A Figma file reorganization and templatification initiative is in progress to streamline development handoff and reduce rework — improving mockup clarity and feature workflow documentation to directly address stability and quality issues in the platform.
  • A formative usability study, planned to complete before the end of Q1, will test workflow improvements for two distinct user groups, with findings shared broadly across the project team to raise awareness of user needs, feedback, and use-related risks.
  • Working with business and product stakeholders, we aligned on a new process for feature definition that carves out dedicated time for UX research and competitive analyses — embedding design thinking earlier in the product development cycle, not as a downstream service.
Figma reorganization underway to reduce dev rework and platform instability
Formative usability study planned for Q1 — findings shared project-wide
Feature definition process updated to include UX research time
Direct access secured to senior Roche pathology lab leadership
2026 UX roadmap
Next Case Study Drawing users' attention to the right place at the right time.

Get in touch

Interested in connecting?

I'm always open to discussing new opportunities, collaborations, or just a good design conversation.